165
Articles
10K
Citations
9.2
avg. Impact Factor
51
h-index

Most Cited Articles of Department of Surgery

TitleJournalYearCitations
Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 VirusCell20202.3K
Initial B-cell responses to transmitted human immunodeficiency virus type 1: virion-binding immunoglobulin M (IgM) and IgG antibodies followed by plasma anti-gp41 antibodies with ineffective control of initial viremiaJournal of Virology2008452
Vaccine-induced Env V1-V2 IgG3 correlates with lower HIV-1 infection risk and declines soon after vaccinationScience Translational Medicine2014336
Profiling the specificity of neutralizing antibodies in a large panel of plasmas from patients chronically infected with human immunodeficiency virus type 1 subtypes B and CJournal of Virology2008305
Vaccine-induced plasma IgA specific for the C1 region of the HIV-1 envelope blocks binding and effector function of IgGProceedings of the National Academy of Sciences of the United States of America2013301
Heterogeneous neutralizing antibody and antibody-dependent cell cytotoxicity responses in HIV-1 elite controllersAids2009252
SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral spike vaccinesCell Host and Microbe2021225
Maturation Pathway from Germline to Broad HIV-1 Neutralizer of a CD4-Mimic AntibodyCell2016209
D614G Spike Mutation Increases SARS CoV-2 Susceptibility to NeutralizationCell Host and Microbe2021198
An HIV-1 gp120 envelope human monoclonal antibody that recognizes a C1 conformational epitope mediates potent antibody-dependent cellular cytotoxicity (ADCC) activity and defines a common ADCC epitope in human HIV-1 serumJournal of Virology2011180
Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19)Lancet, The2018170
A group M consensus envelope glycoprotein induces antibodies that neutralize subsets of subtype B and C HIV-1 primary virusesVirology2006161
Polyclonal B cell responses to conserved neutralization epitopes in a subset of HIV-1-infected individualsJournal of Virology2011148
HIV-1 vaccine-induced C1 and V2 Env-specific antibodies synergize for increased antiviral activitiesJournal of Virology2014140
H3N2 influenza infection elicits more cross-reactive and less clonally expanded anti-hemagglutinin antibodies than influenza vaccinationPLoS ONE2011139
Two distinct broadly neutralizing antibody specificities of different clonal lineages in a single HIV-1-infected donor: implications for vaccine designJournal of Virology2012132
Polyclonal B cell differentiation and loss of gastrointestinal tract germinal centers in the earliest stages of HIV-1 infectionPLoS Medicine2009129
Staged induction of HIV-1 glycan-dependent broadly neutralizing antibodiesScience Translational Medicine2017127
Conceptual Approaches to Modulating Antibody Effector Functions and Circulation Half-LifeFrontiers in Immunology2019126
Isolation of a human anti-HIV gp41 membrane proximal region neutralizing antibody by antigen-specific single B cell sortingPLoS ONE2011123
D614G Mutation Alters SARS-CoV-2 Spike Conformation and Enhances Protease Cleavage at the S1/S2 JunctionCell Reports2021123
Effect of natural mutations of SARS-CoV-2 on spike structure, conformation, and antigenicityScience2021121
Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trialScience2022116
High-Throughput Mapping of B Cell Receptor Sequences to Antigen SpecificityCell2019106
Recurrent signature patterns in HIV-1 B clade envelope glycoproteins associated with either early or chronic infectionsPLoS Pathogens2011104